Guwahati, April 29 -- Indian Institute of Technology, Guwahati (IIT-G) is collaborating with Hester Biosciences Limited - a pharmaceutical company based in Ahmedabad in Gujarat, to work on the vaccine development against COVID-19.

The agreement between the two parties was signed on Apr 15.In a press release issued by IIT-G said that, the vaccine will be based on recombinant avian paramyxovirus based vector platform. The recombinant avian paramyxovirus-1 will be used to express the immunogenic protein of SARS-CoV-2.The recombinant avian paramyxovirus-1 expressing the SARS-CoV-2 protein could be used as a vaccine candidate for further study.The avian paramyxovirus-1 has been explored as a vaccine vector for various animals and human pathog...